跳至主要内容
临床试验/NCT02139670
NCT02139670已完成不适用

Thrombin Generation and Gestational Outcome in Women With Recurrent Pregnancy Loss

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
1
主要终点
pregnancy outcome

研究概览

简要总结

In total 120 pregnant women's with history of recurrent miscarriages, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). The relation between pregnancy outcome and thrombin measurements will be determined

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age > 18
  • signed inform consent
  • first trimester
  • two early miscarriages(before week 10) or one later abortions (after week 10)

排除标准

  • Chronic treatment with aspirin or other anticoagulants

结局指标

主要结局

pregnancy outcome

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elias mazen

Director of Internal medicine

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验